D-다이머 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The D-dimer Testing Market size is expected to reach USD 3.83 Billion in 2034 from USD 2.56 Billion (2025) growing at a CAGR of 4.58% during 2026-2034.

The global D-dimer testing market is expanding rapidly as healthcare providers increasingly rely on diagnostic tests to detect blood clotting disorders and thrombotic conditions. D-dimer testing is widely used in diagnosing conditions such as deep vein thrombosis (DVT), pulmonary embolism, and disseminated intravascular coagulation. The growing prevalence of cardiovascular diseases and coagulation disorders worldwide has significantly increased the demand for efficient and accurate diagnostic tools, driving the adoption of D-dimer tests in hospitals and diagnostic laboratories.

Several factors are contributing to the growth of the D-dimer testing market, including advancements in diagnostic technologies and the increasing availability of rapid testing kits. The expansion of healthcare infrastructure and the rising focus on early disease detection are encouraging healthcare providers to incorporate advanced diagnostic solutions. Additionally, the aging global population and increasing surgical procedures are contributing to higher demand for D-dimer tests to assess the risk of clot-related complications.

In the future, the D-dimer testing market is expected to grow further with the integration of automated diagnostic systems and point-of-care testing solutions. The development of high-sensitivity assays and portable diagnostic devices is improving testing efficiency and accessibility. Moreover, increasing awareness regarding thrombotic disorders and the expansion of diagnostic services in emerging economies are likely to create new opportunities for market growth during the forecast period.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Analyzers
• Reagents & Consumables

By Test Type

• Clinical Laboratory Tests
• Point-of-Care Tests

By Method

• Enzyme-linked Immunosorbent Assay (ELISA)
• Latex-enhanced Immunoturbidimetric Assays
• Fluorescence Immunoassays
• Others

By Application

• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Disseminated Intravascular Coagulation (DIC)
• Others

By End Use

• Hospitals
• Academic & Research Institutes
• Diagnostic Centers

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, F HoffmannLa Roche Ltd, Siemens Healthcare, Abbott, Biomrieux, Werfen, Horiba Ltd, QuidelOrtho Corporation, Diazyme Laboratories, Biomedica Diagnostics, Sekisui Diagnostics
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL D-DIMER TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Analyzers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL D-DIMER TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Clinical Laboratory Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Point-of-Care Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL D-DIMER TESTING MARKET: BY METHOD 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Method
• 6.2. Enzyme-linked Immunosorbent Assay (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Latex-enhanced Immunoturbidimetric Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Fluorescence Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL D-DIMER TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Deep Vein Thrombosis (DVT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pulmonary Embolism (PE) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Disseminated Intravascular Coagulation (DIC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL D-DIMER TESTING MARKET: BY END USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End Use
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL D-DIMER TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Test Type
  • 9.2.3 By Method
  • 9.2.4 By Application
  • 9.2.5 By End Use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Test Type
  • 9.3.3 By Method
  • 9.3.4 By Application
  • 9.3.5 By End Use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Test Type
  • 9.4.3 By Method
  • 9.4.4 By Application
  • 9.4.5 By End Use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Test Type
  • 9.5.3 By Method
  • 9.5.4 By Application
  • 9.5.5 By End Use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Test Type
  • 9.6.3 By Method
  • 9.6.4 By Application
  • 9.6.5 By End Use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL D-DIMER TESTING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Thermo Fisher Scientific Inc
  • 11.2.2 F. Hoffmann-La Roche Ltd
  • 11.2.3 Siemens Healthcare
  • 11.2.4 Abbott
  • 11.2.5 Biomerieux
  • 11.2.6 Werfen
  • 11.2.7 Horiba Ltd
  • 11.2.8 QuidelOrtho Corporation
  • 11.2.9 Diazyme Laboratories
  • 11.2.10 Biomedica Diagnostics
  • 11.2.11 Sekisui Diagnostics